dApagliflozin SC0062 and Prevention of Renal Injury; a Randomized Evaluation

NCT06072326 · clinicaltrials.gov ↗

PHASE2

Phase

NOT_YET_RECRUITING

Status

36

Enrollment

OTHER

Sponsor class

Conditions

Type 1 Diabetes Mellitus With Diabetic Nephropathy

Interventions

DRUG: Dapagliflozin (Forxiga®)
DRUG: SC0062 strength 10mg
DRUG: SC0062 and dapagliflozin

Sponsor

University Medical Center Groningen

Collaborators

[object Object]
[object Object]